Filsuvez
- Prescription status not stated
- Skin
- Active substance
- Birch bark extract
- Used in
- Skin
- Made by
- Chiesi Farmaceutici S.p.A
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in patients 6 months and older.
From the official label · 2026-09-30 · European Medicines Agency
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Chiesi Farmaceutici S.p.A |
|---|---|
| Active substance | Birch bark extract |
| Used in | Skin |
| Classification | D03AX13 · Skin |
| Orphan medicine | Yes — designated for a rare disease, according to the register |
| Authorised on | 2022-06-21 |
| Last updated by the regulator | 2025-07-11 |
| EMA product number | EMEA/H/C/005035 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.